Extensive modeling-based bone formation after 2 months of romosozumab treatment: Results from the FRAME clinical trial

Extensive modeling-based bone formation after 2 months of romosozumab treatment: Results from the FRAME clinical trial

Bibliographic Details
Main Authors:	Erik F. Eriksen, Roland Chapurlat, Rogely Boyce, Jacques P. Brown, Stéphane Horlait, Cesar Libanati, Yifei Shi, Rachel B. Wagman, Pascale Chavassieux
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Bone Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S235218722030200X

Similar Items

Skeletal responses to romosozumab after 12 months of denosumab
by: Michael R. McClung, et al.
Published: (2021-07-01)

Interest of Bone Histomorphometry in Bone Pathophysiology Investigation: Foundation, Present, and Future
by: Pascale Chavassieux, et al.
Published: (2022-07-01)

Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial
by: Jacques P. Brown, et al.
Published: (2020-10-01)

The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study
by: Piet Geusens, et al.
Published: (2019-10-01)

Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals
by: Felicia Cosman, et al.
Published: (2021-11-01)

Romosozumab for the treatment of osteoporosis
by: Michael R. McClung
Published: (2018-03-01)

Romosozumab and cardiovascular safety in Japan
by: Yasuhiro Takeuchi
Published: (2021-09-01)

Romosozumab in osteoporosis: yesterday, today and tomorrow
by: Dong Wu, et al.
Published: (2023-09-01)

Romosozumab-associated medication-related osteonecrosis of the jaw
by: Benjamin Palla, et al.
Published: (2023-06-01)

Profile of romosozumab and its potential in the management of osteoporosis
by: Lim SY, et al.
Published: (2017-04-01)

Glucocorticoid-Induced Osteoporosis: The Potential Role of Romosozumab
by: Jacqueline So, et al.
Published: (2020-12-01)

Denosumab versus romosozumab for postmenopausal osteoporosis treatment
by: Tomonori Kobayakawa, et al.
Published: (2021-06-01)

Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
by: Nicole Trepanowski, MD, et al.
Published: (2023-12-01)

Impact of romosozumab on serum calcium concentration and factors predicting the fluctuations in calcium concentration upon romosozumab administration: A multicenter retrospective study
by: Hiroyuki Inose, et al.
Published: (2022-12-01)

The potential effect of romosozumab on perioperative management for instrumentation surgery
by: Koji Ishikawa, et al.
Published: (2024-09-01)

Therapeutic Drug Review on Romosozumab: The First Sclerostin Inhibitor
by: Vijay Kumar Jain, et al.
Published: (2022-04-01)

Effect of romosozumab in premenopausal women with severe osteoporosis and anorexia nervosa
by: Kazuki Fujimoto, et al.
Published: (2023-12-01)

Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
by: Sian Yik Lim
Published: (2022-09-01)

Romosozumab: A new anabolic arrow in quiver for management of osteoporosis
by: Alok Singh, et al.
Published: (2020-01-01)

Sclerostin and Cardiovascular Risk: Evaluating the Cardiovascular Safety of Romosozumab in Osteoporosis Treatment
by: Shi-Hsun Chiu, et al.
Published: (2024-12-01)

Comparison of the Efficacy of Romosozumab and Teriparatide for the Management of Osteoporotic Vertebral Compression Fractures
by: Danbi Park, et al.
Published: (2023-12-01)

Clinical Utility of Romosozumab in the Management of Osteoporosis: Focus on Patient Selection and Perspectives
by: Lim SY, et al.
Published: (2022-12-01)

Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab?
by: David M. Reid
Published: (2020-01-01)

Romosozumab rescues impaired bone mass and strength in a murine model of diabetic kidney disease
by: Rachel Kohler, et al.
Published: (2024-06-01)

Comparison of Denosumab with Romosozumab in the treatment of male osteoporosis: a retrospective cohort study
by: Tomonori Kobayakawa, et al.
Published: (2024-10-01)

Effectiveness of romosozumab in primary biliary cholangitis at half the recommended dose in an underweight patient
by: Bhanvi Ramchandani, et al.
Published: (2024-03-01)

Osteoporosis Improved by Romosozumab Therapy in a Patient With Type I Osteogenesis Imperfecta
by: Antara Dattagupta, MD, MEng, et al.
Published: (2023-11-01)

Pregnancy and Lactation-Associated Osteoporosis Successfully Treated with Romosozumab: A Case Report
by: Yoichi Kaneuchi, et al.
Published: (2022-12-01)

The Automatic Proportionator Estimator Is Highly Efficient for Estimation of Total Number of Sparse Cell Populations
by: Rogely W. Boyce, et al.
Published: (2018-03-01)

The Effects of Switch Therapy in Osteoporosis Treatment after Romosozumab after Comparing with Prior Treatment
by: Akira Horikawa, et al.
Published: (2024-01-01)

The effects of romosozumab combined with active vitamin D3 on fracture healing in ovariectomized rats
by: Ryota Takase, et al.
Published: (2022-08-01)

Comparison of osteoanabolic agents (teriparatide and romosozumab) with bisphosphonates in prevention of subsequent vertebral fractures in patients treated for osteoporotic vertebral fracture for 12 months: An observational cohort study
by: Keishi Maruo, et al.
Published: (2024-06-01)

Cost-effectiveness analysis of romosozumab for severe postmenopausal osteoporosis at very high risk of fracture in Mexico.
by: Juan Pablo Diaz Martinez, et al.
Published: (2025-01-01)

Romosozumab not only enhanced bone mineral density but also improve back pain and life quality
by: Chung-Hwan Chen, et al.
Published: (2023-12-01)

Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
by: Mingwei Hu, et al.
Published: (2023-07-01)

Romosozumab and blosozumab: alternative drugs of mechanical strain-related stimulus toward a cure for osteoporosis
by: Toshihiro eSugiyama, et al.
Published: (2015-04-01)

Clinical efficacy of romosozumab in the treatment of elderly male patients of osteoporotic with hip fractures: a retrospective study
by: Yichao Ji, et al.
Published: (2025-01-01)

Papel del Romosozumab en la práctica clínica a la luz de la evidencia
by: Alejandro Román-González, et al.
Published: (2022-01-01)

Osteoporosis clinical practice guideline: romosozumab for treating severe osteoporosis – an update by the Egyptian Academy of Bone Health
by: Yasser El Miedany, et al.
Published: (2022-09-01)

Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study
by: Tomonori Kobayakawa, et al.
Published: (2021-06-01)